Jaguar Health (STU:1JA) Current Accrued Expense : €3.10 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Jaguar Health Current Accrued Expense?

Jaguar Health's Current Accrued Expense for the quarter that ended in Jun. 2024 was €3.10 Mil.

Jaguar Health's quarterly Current Accrued Expense declined from Dec. 2023 (€3.22 Mil) to Mar. 2024 (€3.19 Mil) and declined from Mar. 2024 (€3.19 Mil) to Jun. 2024 (€3.10 Mil).

Jaguar Health's annual Current Accrued Expense increased from Dec. 2021 (€5.85 Mil) to Dec. 2022 (€7.16 Mil) but then declined from Dec. 2022 (€7.16 Mil) to Dec. 2023 (€3.22 Mil).

Jaguar Health Current Accrued Expense Historical Data

The historical data trend for Jaguar Health's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jaguar Health Current Accrued Expense Chart

Jaguar Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2.41

3.59

5.85

7.16

3.22

Jaguar Health Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Accrued Expense	Get a 7-Day Free Trial															9.25	3.08	3.22	3.19	3.10

Jaguar Health Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Jaguar Health Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Jaguar Health's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Jaguar Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jaguar Health Inc (STU:1JA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

JAGX:USA

Address

200 Pine Street, Suite 400, San Francisco, CA, USA, 94104

Website

http://www.jaguar.health

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Jaguar Health Headlines

No Headlines